DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Low Dose of Diltiazem for Rate Control of Atrial Fibrillation

Information source: Seoul National University Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Atrial Fibrillation

Intervention: low dose diltiazem (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Seoul National University Hospital

Overall contact:
Kyuseok Kim, Phone: +82-31-787-3049, Email: dremkks@snubh.org

Summary

This study is to show the efficacy and safety of low dose diltiazem for the treatment of atrial fibrillation with rapid ventricular response in emergency room. We will compare the standard dose of diltiazem(0. 25mg/kg) with low dose diltiazem(0. 1mg/kg)in atrial fibrillation with rapid ventricular response in ED.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Success rate of rate control

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- atrial fibrillation with rapid ventricular response in emergency room

Exclusion Criteria:

- age<18

- systolic blood pressure<90mmHg

- no consent

Locations and Contacts

Kyuseok Kim, Phone: +82-31-787-3049, Email: dremkks@snubh.org

Seoul National University Hospital, Seoul, Korea, Republic of; Recruiting
Sang Hoon Na, MD, PhD, Phone: +82-2-2072-3047, Email: nasanghoon@gmail.com
Additional Information

Starting date: August 2009
Last updated: July 25, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017